PKP2

Clinical trials for PKP2 explained in plain language.

Never miss a new study

Get alerted when new PKP2 trials appear

Sign up with your email to follow new studies for PKP2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Experimental drug targets deadly heart rhythm disorder

Disease control Terminated

This early-stage study is testing whether an experimental drug called IC14 can help control arrhythmogenic cardiomyopathy, a serious heart condition that causes dangerous irregular heartbeats. Five patients who already have implanted defibrillators will receive four intravenous i…

Matched conditions: PKP2

Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

PKP2

Get alerted when new PKP2 trials appear

Experimental drug targets deadly heart rhythm disorder